- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 498/16 - Peri-condensed systems
Patent holdings for IPC class C07D 498/16
Total number of patents in this class: 276
10-year publication summary
|
14
|
12
|
8
|
19
|
14
|
17
|
22
|
44
|
27
|
15
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Merck Sharp & Dohme LLC | 3736 |
12 |
| Genentech, Inc. | 4110 |
9 |
| Merck Patent GmbH | 5729 |
9 |
| ImmunoGen, Inc. | 378 |
9 |
| Bristol-myers Squibb Company | 4751 |
7 |
| Gilead Sciences, Inc. | 2226 |
7 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 774 |
6 |
| Gilead Pharmasset LLC | 40 |
6 |
| Incyte Holdings Corporation | 625 |
6 |
| Lupin Limited | 439 |
5 |
| Jacobio Pharmaceuticals Co., Ltd. | 104 |
5 |
| Turning Point Therapeutics, Inc. | 98 |
5 |
| Nikang Therapeutics, Inc. | 108 |
5 |
| Shanghai Blueray Biopharma Co., Ltd. | 26 |
5 |
| Kumquat Biosciences Inc. | 84 |
5 |
| Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 377 |
4 |
| Universal Display Corporation | 2088 |
4 |
| Fulcrum Therapeutics, Inc. | 55 |
4 |
| Samsung Display Co., Ltd. | 38676 |
3 |
| Bayer AG | 3499 |
3 |
| Other owners | 157 |